Conception and design: Jun J. Yang, Cheng Cheng, Wing Leung, Jing Chen, Jun Lu, Benshang Li, Ching-Hon Pui

Financial support: Benshang Li

Administrative support: Jing Chen, Benshang Li

Provision of study materials or patients: Tianyi Wang, Yanjing Tang, Fan Yang, Qing Cao, Juan Qian, Kang An, Chengjuan Luo, Xiang Wang, Wenhua Shi, Peifang Xiao, Xiaomin Yang, Jing Yang, Jingyan Tang, Wing Leung, Jing Chen, Jun Lu, Benshang Li

Collection and assembly of data: Tianyi Wang, Yanjing Tang, Jiaoyang Cai, Xinyu Wan, Shaoyan Hu, Xiaoxi Lu, Zhiwei Xie, Hui Jiang, Jingbo Shao, Fan Yang, Qing Cao, Jian Zhang, Jianmin Wang, Chengjuan Luo, Yan Miao, Xiang Wang, Lili Song, Hailong He, Wenhua Shi, Peifang Xiao, Xiaomin Yang, Jing Yang, Yiping Zhu, Ningling Wang, Longjun Gu, Qimin Chen, Jingyan Tang, Jun Lu, Ching-Hon Pui

Data analysis and interpretation: Yanjing Tang, Jiaoyang Cai, Xinyu Wan, Xiaohong Qiao, Hong Ren, Qing Cao, Juan Qian, Kang An, Chengjuan Luo, Huanhuan Liang, Yani Ma, Lixia Ding, Xiaomin Yang, Jing Yang, Wenjie Li, Yiping Zhu, Jingyan Tang, Cheng Cheng, Wing Leung, Jing Chen, Jun Lu, Ching-Hon Pui

Manuscript writing: All authors

Final approval of manuscript: All authors

Accountable for all aspects of the work: All authors

AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Jun J. Yang

Research Funding: Takeda (Inst)

Wing Leung

Employment: Miltenyi Biotec

Ching-Hon Pui

Leadership: Adaptive Biotechnologies

Honoraria: Novartis

Consulting or Advisory Role: Adaptive Biotechnologies

Research Funding: National Cancer Institute

No other potential conflicts of interest were reported.